Source: Annals of oncology. Unidade: FM
Subjects: IMUNOHISTOQUÍMICA, ANTINEOPLÁSICOS, NEOPLASIAS PULMONARES, CÉLULAS CULTIVADAS DE TUMOR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HERBST, R. S et al. Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trial. Annals of oncology, v. 30, n. 2, p. 281-289, 2019Tradução . . Disponível em: https://doi.org/10.1093/annonc/mdy545. Acesso em: 28 ago. 2024.APA
Herbst, R. S., Baas, P., Perez-gracia, J. L., Felip, E., Kim, D. -W., Han, J. -Y., et al. (2019). Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trial. Annals of oncology, 30( 2), 281-289. doi:10.1093/annonc/mdy545NLM
Herbst RS, Baas P, Perez-gracia JL, Felip E, Kim D-W, Han J-Y, Molina JR, Kim J-H, Arvis CD, Castro Junior G de. Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trial [Internet]. Annals of oncology. 2019 ; 30( 2): 281-289.[citado 2024 ago. 28 ] Available from: https://doi.org/10.1093/annonc/mdy545Vancouver
Herbst RS, Baas P, Perez-gracia JL, Felip E, Kim D-W, Han J-Y, Molina JR, Kim J-H, Arvis CD, Castro Junior G de. Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trial [Internet]. Annals of oncology. 2019 ; 30( 2): 281-289.[citado 2024 ago. 28 ] Available from: https://doi.org/10.1093/annonc/mdy545
